ArticlePharmaceutics2023

Physiologically Based Pharmacokinetic Modelling to Predict Pharmacokinetics of Enavogliflozin, a Sodium-Dependent Glucose Transporter 2 Inhibitor, in Humans.

Min-Soo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.